SK284155B6 - Farmaceutický prostriedok obsahujúci levotyroxín nátrium a spôsob jeho výroby - Google Patents

Farmaceutický prostriedok obsahujúci levotyroxín nátrium a spôsob jeho výroby Download PDF

Info

Publication number
SK284155B6
SK284155B6 SK1689-2000A SK16892000A SK284155B6 SK 284155 B6 SK284155 B6 SK 284155B6 SK 16892000 A SK16892000 A SK 16892000A SK 284155 B6 SK284155 B6 SK 284155B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
sodium
levothyroxine sodium
composition according
levothyroxine
Prior art date
Application number
SK1689-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK16892000A3 (sk
Inventor
Sven Schreder
Marion Nischwitz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK16892000A3 publication Critical patent/SK16892000A3/sk
Publication of SK284155B6 publication Critical patent/SK284155B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK1689-2000A 1998-05-15 1999-05-05 Farmaceutický prostriedok obsahujúci levotyroxín nátrium a spôsob jeho výroby SK284155B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19821625A DE19821625C1 (de) 1998-05-15 1998-05-15 Pharmazeutische Zubereitung
PCT/EP1999/003087 WO1999059551A1 (de) 1998-05-15 1999-05-05 Levothyroxin natrium enthaltende pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
SK16892000A3 SK16892000A3 (sk) 2001-04-09
SK284155B6 true SK284155B6 (sk) 2004-10-05

Family

ID=7867752

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1689-2000A SK284155B6 (sk) 1998-05-15 1999-05-05 Farmaceutický prostriedok obsahujúci levotyroxín nátrium a spôsob jeho výroby

Country Status (25)

Country Link
US (2) US6646007B1 (cs)
EP (1) EP1077681B1 (cs)
JP (1) JP4709379B2 (cs)
CN (1) CN1145479C (cs)
AR (1) AR018607A1 (cs)
AT (1) ATE225651T1 (cs)
AU (1) AU742382B2 (cs)
BR (1) BRPI9910445B8 (cs)
CA (1) CA2333193A1 (cs)
CZ (1) CZ300908B6 (cs)
DE (2) DE19821625C1 (cs)
DK (1) DK1077681T3 (cs)
ES (1) ES2184452T3 (cs)
HU (1) HU228958B1 (cs)
ID (1) ID27281A (cs)
MY (1) MY120570A (cs)
NO (1) NO331655B1 (cs)
PL (1) PL194088B1 (cs)
PT (1) PT1077681E (cs)
RU (1) RU2225711C2 (cs)
SK (1) SK284155B6 (cs)
TW (1) TW561058B (cs)
UA (1) UA73474C2 (cs)
WO (1) WO1999059551A1 (cs)
ZA (1) ZA200007509B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2438641A1 (en) 2001-02-15 2002-08-22 King Pharmaceuticals, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
WO2004041208A2 (en) * 2002-11-05 2004-05-21 New River Pharmaceuticals Inc. Controlled absorption of mixed thyroyd hormone formulations
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
GB0316206D0 (en) * 2003-07-10 2003-08-13 Glaxo Group Ltd Pharmaceutical formulation
DE602004012904T2 (de) 2004-11-18 2009-04-16 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator
GB0525461D0 (en) * 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
SG11201501122WA (en) * 2012-08-20 2015-03-30 Merck Patent Gmbh Solid pharmaceutical preparation containing levothyroxine
EP2932963A1 (en) 2014-04-16 2015-10-21 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable pharmaceutical dosage forms comprising Levothyroxine sodium
IN2014MU03703A (cs) 2014-11-21 2016-07-22
WO2018069805A2 (en) 2016-10-10 2018-04-19 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
CN109010295A (zh) * 2018-08-29 2018-12-18 北京兴源联合医药科技有限公司 一种左甲状腺素钠冻干口腔崩解片
CN115737576B (zh) * 2022-11-14 2024-05-07 山东创新药物研发有限公司 一种左甲状腺素钠片剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6191M (cs) * 1966-02-18 1968-07-22
US3808332A (en) * 1969-01-27 1974-04-30 Armour Pharma Pharmaceutical compositions containing the reaction product of a tertiary phosphine with thyroxine
US3621098A (en) 1969-03-17 1971-11-16 Geigy Chem Corp HYPOTENSIVE METHODS AND COMPOSITIONS UTILIZING HEXAHYDROBENZO{8 b{9 {0 QUINOLIZINES
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
DE2126533A1 (de) * 1971-05-28 1972-12-14 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung pharma zeutischer Zubereitungen
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
US5225204A (en) 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
ES2107235T3 (es) * 1993-06-14 1997-11-16 Janssen Pharmaceutica Nv Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
CA2134611C (en) * 1994-10-28 2002-12-24 Richard John Yarwood Process for preparing solid pharmaceutical dosage forms
SE9500897D0 (sv) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cystine derivatives
CN1126589A (zh) 1995-06-09 1996-07-17 中国科学院成都有机化学研究所 一种激素缓释微囊注射剂及其制备方法
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US5635209A (en) * 1995-10-31 1997-06-03 Vintage Pharmaceuticals, Inc. Stabilized composition of levothyroxine sodium medication and method for its production
DE69633018T2 (de) * 1995-11-14 2004-12-09 Abbott Gmbh & Co. Kg Schilddrüsenhormone enthaltende stabilisierte arzneimittel und verfahren
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
RU2129005C1 (ru) * 1996-05-21 1999-04-20 Михеева Элеонора Федоровна Сбор для восстановления функции щитовидной железы
US20010039335A1 (en) * 1997-04-10 2001-11-08 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
DE19830246A1 (de) * 1998-07-07 2000-01-13 Merck Patent Gmbh Pharmazeutische Zubereitung

Also Published As

Publication number Publication date
MY120570A (en) 2005-11-30
ZA200007509B (en) 2002-06-14
CZ20004201A3 (cs) 2001-03-14
CN1301148A (zh) 2001-06-27
JP2002515421A (ja) 2002-05-28
ES2184452T3 (es) 2003-04-01
US6646007B1 (en) 2003-11-11
DK1077681T3 (da) 2002-12-30
CZ300908B6 (cs) 2009-09-09
HUP0102125A2 (hu) 2001-11-28
DE59903028D1 (de) 2002-11-14
BR9910445A (pt) 2001-01-02
US20040063611A1 (en) 2004-04-01
RU2225711C2 (ru) 2004-03-20
DE19821625C1 (de) 2000-01-05
TW561058B (en) 2003-11-11
ATE225651T1 (de) 2002-10-15
HU228958B1 (en) 2013-07-29
UA73474C2 (uk) 2005-08-15
NO20005758L (no) 2000-11-14
PT1077681E (pt) 2003-02-28
PL346395A1 (en) 2002-02-11
HUP0102125A3 (en) 2001-12-28
NO20005758D0 (no) 2000-11-14
JP4709379B2 (ja) 2011-06-22
WO1999059551A1 (de) 1999-11-25
CA2333193A1 (en) 1999-11-25
AU3932199A (en) 1999-12-06
AU742382B2 (en) 2002-01-03
BRPI9910445B1 (pt) 2017-05-09
PL194088B1 (pl) 2007-04-30
CN1145479C (zh) 2004-04-14
ID27281A (id) 2001-03-22
AR018607A1 (es) 2001-11-28
NO331655B1 (no) 2012-02-13
US8008349B2 (en) 2011-08-30
BRPI9910445B8 (pt) 2021-05-25
EP1077681B1 (de) 2002-10-09
SK16892000A3 (sk) 2001-04-09
EP1077681A1 (de) 2001-02-28

Similar Documents

Publication Publication Date Title
SK284155B6 (sk) Farmaceutický prostriedok obsahujúci levotyroxín nátrium a spôsob jeho výroby
US5151433A (en) Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
AU712217B2 (en) Stabilized thyroid hormone preparations and methods of making same
CA1338553C (en) Pharmaceutical granulate containing cellulose product
ES2736022T3 (es) Composición farmacéutica que comprende pimobendán
JPH0751504B2 (ja) 直打用ビタミン顆粒、その製造法および錠剤
RU2300368C2 (ru) Содержащая ибупрофен композиция
JPH0753663B2 (ja) チアミン塩の顆粒,その製造法および錠剤
HUP0104985A2 (hu) Levotiroxint tartalmazó gyógyszerkészítmények és eljárás az előállításukra
FI103015B (fi) Menetelmä tabletti- tai raekoostumuksen valmistamiseksi, joka sisältää lämmölle, valolle ja kosteudelle herkkää aktiivista aineosaa, jolla o n monokliininen kiderakenne
JP4293572B2 (ja) ロキソプロフェン・ナトリウム含有錠剤
JP2521612B2 (ja) 直接錠剤形成助剤
FI89455B (fi) Foerfarande foer framstaellning av en farmaceutisk komposition
MXPA00011182A (en) Pharmaceutical preparation containing levothyroxine sodium
WO2023182332A1 (ja) 口腔内崩壊錠用の添加剤組成物
JP2003119121A (ja) 錠剤の製造方法
CA2259212A1 (en) Ephedrine in granular form with a high active substance content
HK1038192A (en) Pharmaceutical preparation containing levothyroxine sodium

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20190505